Epigenetics: A Molecular Link Between Environmental Factors and Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 116 of the 117 references it cites were found in a registry or an index.
Abstract
A lthough obesity, reduced physical activity, andaging increase susceptibility to type 2 diabetes,many people exposed to these risk factors donot develop the disease. Recent genome-wide association studies have identified a number of genetic variants that explain some of the interindividual variation in diabetes susceptibility (1–5). There is also a growing body of literature suggesting a role for epigenetic factors in the complex interplay between genes and the environ-ment. Nevertheless, our knowledge about the molecular mechanisms linking environmental factors and type 2 diabetes still remains limited. This perspective will pro-vide some insights into epigenetic mechanisms associated with type 2 diabetes. An overview of epigenetic regulation. Although there is no uniform definition of epigenetics, it has been de-scribed as heritable changes in gene function that occur without a change in the nucleotide sequence (6). Epige-
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“For example, changes in human epigenome have been associated with processes related to adaptation and evolution (64, 65), and have also been linked to several diseases, such as cancer (66), type 2 diabetes (67), and autoimmune rheumatic disorders, such as systemic lupus erythematosus (SLE) (68).”
From Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma (2019) · cites this paper as [67]
The cited source says what the claim attributes to it.
In the citing paper
“Interestingly, epigenetic mechanisms may also contribute to these patterns because reduced expression parallels increased DNA methylation of both the COX7A1 promoter (136) and NDUFB6 (137, 139).”
From The role of mitochondria in the pathogenesis of type 2 diabetes (2010) · cites this paper as [139]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Reddy, M. A., Villeneuve, L. M., Wang, M., Lanting, L. L., & Natarajan, R. D. (2008) · Circulation Research · doi:10.1161/circresaha.108.175190 · Cited by 83 · cited 3×
“, IL-6 and MCP-1, in parallel with decreased levels of the H3K9me3 methyltransferase Suv39h1 and a histone demethylase, the lysine-specific demethylase 1 (LSD1) (103,104).”
BackgroundRetractedChromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197 · cited 1×
“COX7A1, which is part of complex 4 of the respiratory chain and which shows decreased expression in diabetic muscle, is a target of age-related DNA methylation (23,34).”
BackgroundSelf-citationEffects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397 · cited 1×
“risk of macrovascular complications (106,107).”
Epigenetic differences arise during the lifetime of monozygotic twins
Fraga, M. F., Ballestar, E., Paz, M. F., Ropero, S., Setien, F., Ballestar, M. L., Heine-Suñer, D., Cigudosa, J. C., Urioste, M., Benitez, J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500398102 · Cited by 3,602
Self-citationPersistent epigenetic differences associated with prenatal exposure to famine in humans
Heijmans, B. T., Tobi, E. W., Stein, A. D., Putter, H., Blauw, G. J., Susser, E. S., Slagboom, P. E., & Lumey, L. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806560105 · Cited by 3,082
DNA methylation landscapes: Provocative insights from epigenomics
Suzuki, M. M., & Bird, A. (2008) · Nature Reviews Genetics · doi:10.1038/nrg2341 · Cited by 3,039 · cited 1×
“New techniques have made it easier to analyze DNA methylation and histone modifications on a genome-wide scale (19,20).”
BackgroundBird, A. (2007) · Nature · doi:10.1038/nature05913 · Cited by 3,011 · cited 1×
“Although there is no uniform definition of epigenetics, it has been described as heritable changes in gene function that occur without a change in the nucleotide sequence (6).”
BackgroundA genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Cited by
Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62154-6 · Cited by 1,743
Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?
Martín-Timón, I. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i4.444 · Cited by 976
Rönn, T., Volkov, P., Davegårdh, C., Dayeh, T., Hall, E., Olsson, A. H., Nilsson, E., Tornberg, Å., Dekker Nitert, M., Eriksson, K.-F., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003572 · Cited by 618
Self-citationThe role of mitochondria in the pathogenesis of type 2 diabetes
Patti, M.-E., & Corvera, S. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0027 · Cited by 551
Impact of diabetes on cardiovascular disease: an update
Matheus, A. S. D. M., Tannus, L. R. M., Cobas, R. A., Palma, C. C. S., Negrato, C. A., & Gomes, M. D. B. (2013) · International Journal of Hypertension · doi:10.1155/2013/653789 · Cited by 547
Dayeh, T., Volkov, P., Salö, S., Hall, E., Nilsson, E., Olsson, A. H., Kirkpatrick, C. L., Wollheim, C. B., Eliasson, L., Rönn, T., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004160 · Cited by 523
“Epigenetic alterations may subsequently influence phenotype transmission and the development of different diseases, including T2D [7,10].”
Self-citationEpigenetic mechanisms in diabetic complications and metabolic memory
Reddy, M. A., Zhang, E., & Natarajan, R. (2015) · Diabetologia · doi:10.1007/s00125-014-3462-y · Cited by 496
Prevalence of Diabetes in India: A Review of IDF Diabetes Atlas 10th Edition
Kumar, A., Gangwar, R., Ahmad Zargar, A., Kumar, R., & Sharma, A. (2024) · Current Diabetes Reviews · doi:10.2174/1573399819666230413094200 · Cited by 375
Nitert, M. D., Dayeh, T., Volkov, P., Elgzyri, T., Hall, E., Nilsson, E., Yang, B. T., Lang, S., Parikh, H., Wessman, Y., et al. (2012) · Diabetes · doi:10.2337/db11-1653 · Cited by 403
Self-citationRole of the gut microbiota in type 2 diabetes and related diseases
Yang, G., Wei, J., Liu, P., Zhang, Q., Tian, Y., Hou, G., Meng, L., Xin, Y., & Jiang, X. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154712 · Cited by 418
Epigenetics and cardiovascular disease
Ordovás, J. M., & Smith, C. E. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.104 · Cited by 402
Nilsson, E., Jansson, P. A., Perfilyev, A., Volkov, P., Pedersen, M., Svensson, M. K., Poulsen, P., Ribel-Madsen, R., Pedersen, N. L., Almgren, P., et al. (2014) · Diabetes · doi:10.2337/db13-1459 · Cited by 391
“One link between environment and disease is epigenetics influencing gene transcription and subsequently organ function (4).”
BackgroundSelf-citationDistinct DNA methylation changes highly correlated with chronological age in the human brain
Hernandez, D. G., Nalls, M. A., Gibbs, J. R., Arepalli, S., van der Brug, M., Chong, S., Moore, M., Longo, D. L., Cookson, M. R., Traynor, B. J., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq561 · Cited by 375
Cradock, K. A., ÓLaighin, G., Finucane, F. M., Gainforth, H. L., Quinlan, L. R., & Ginis, K. A. M. (2017) · International Journal of Behavioral Nutrition and Physical Activity · doi:10.1186/s12966-016-0436-0 · Cited by 343
Diabesity: an overview of a rising epidemic
Farag, Y. M. K., & Gaballa, M. R. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfq576 · Cited by 320
Ollikainen, M., Smith, K. R., Joo, E. J.-H., Ng, H. K., Andronikos, R., Novakovic, B., Abdul Aziz, N. K., Carlin, J. B., Morley, R., Saffery, R., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq336 · Cited by 312
Gertz, J., Varley, K. E., Reddy, T. E., Bowling, K. M., Pauli, F., Parker, S. L., Kucera, K. S., Willard, H. F., & Myers, R. M. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002228 · Cited by 300
“patterns of DNA methylation have been reported in a wide variety of human diseases, including cancer [2,3], psychiatric disorders [4], autoimmune diseases [5] and diabetes [6].”
BackgroundYang, B. T., Dayeh, T. A., Volkov, P. A., Kirkpatrick, C. L., Malmgren, S., Jing, X., Renström, E., Wollheim, C. B., Nitert, M. D., & Ling, C. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1004 · Cited by 301
Self-citationEpigenetics meets endocrinology
Zhang, X., & Ho, S.-M. (2011) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0053 · Cited by 298
“…of www.endocrinology-journals.org Downloaded from Bioscientifica.com at 09/29/2022 08:08:56AM via free access the endocrine glands and their target organs (Crews & McLachlan 2006, Deladoey et al. 2007, Musri et al. 2007, Tang & Ho 2007, Rampersaud et al. 2008, Ling & Groop 2009, Blaustein 2010).”
BackgroundThe role of epigenetics in the pathology of diabetic complications
Villeneuve, L. M., & Natarajan, R. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00200.2010 · Cited by 295
“However, increasing evidence suggests that complex interactions between genes and the environment may play a major role in many common human diseases such as diabetes and its complications (88, 89, 91, 92, 142).”
BackgroundRole of Epigenetics in Biology and Human Diseases.
Moosavi, A., & Ardekani, A. M. (2016) · PubMed · doi:10.22045/ibj.2016.01 · Cited by 273
“In patients with type II diabetes, several genes have been reported to be hypermethylated in muscle, including peroxisome proliferator-activated receptor gamma and coactivator 1-alpha [58,59] .”
BackgroundEpigenetic Modifications in Stress Response Genes Associated With Childhood Trauma
Jiang, S., Postovit, L., Cattaneo, A., Binder, E. B., & Aitchison, K. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00808 · Cited by 288
“For example, changes in human epigenome have been associated with processes related to adaptation and evolution (64, 65), and have also been linked to several diseases, such as cancer (66), type 2 diabetes (67), and autoimmune rheumatic disorders, such as systemic lupus erythematosus (SLE) (68).”
BackgroundHerman, R., Kravos, N. A., Jensterle, M., Janež, A., & Dolžan, V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031264 · Cited by 254
Histone Methyl Transferases and Demethylases; Can They Link Metabolism and Transcription?
Teperino, R., Schoonjans, K., & Auwerx, J. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.09.004 · Cited by 271
“Since the well-established role of DNA methylation (reviewed by Suzuki and Bird, 2008 and Ling and Groop, 2009) and the emerging function of histone acetyltransferases and deacetylases (reviewed by Smith and O’Malley, 2004; Spiegelman and Heinrich, 2004; Rosenfeld et al., 2006; Feige and Auwerx,…”
BackgroundNon-CG Methylation in the Human Genome
He, Y., & Ecker, J. R. (2015) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025437 · Cited by 267
“Growing evidence suggests that chromatin factors are involved in the incidence of T2DM and may mediate the complex interaction between genetic variants, environment, and gene expression (53).”
BackgroundAGE restriction in diabetes mellitus: a paradigm shift
Vlassara, H., & Striker, G. E. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.74 · Cited by 277
Epigenetic modification of nucleic acids: from basic studies to medical applications
Chen, Y., Hong, T., Wang, S., Mo, J., Tian, T., & Zhou, X. (2017) · Chemical Society Reviews · doi:10.1039/c6cs00599c · Cited by 263
Ronn, T., Volkov, P., Gillberg, L., Kokosar, M., Perfilyev, A., Jacobsen, A. L., Jorgensen, S. W., Brons, C., Jansson, P.-A., Eriksson, K.-F., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv124 · Cited by 270
Self-citationIntrauterine programming of obesity and type 2 diabetes
Fernandez-Twinn, D. S., Hjort, L., Novakovic, B., Ozanne, S. E., & Saffery, R. (2019) · Diabetologia · doi:10.1007/s00125-019-4951-9 · Cited by 257
“DNA methylation in promoter regions may induce transcriptional inhibition or repression by affecting transcription-factor binding or recruiting proteins that specifically bind to methylated CpG sites [54].”
BackgroundNutrition, Epigenetics, and Metabolic Syndrome
Wang, J., Wu, Z., Li, D., Li, N., Dindot, S. V., Satterfield, M. C., Bazer, F. W., & Wu, G. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4381 · Cited by 261
“In contrast, phosphorylation of H2B (at serine 14) stimulates apoptosis, which plays an important role in cell metabolism and growth (101).”
Epigenetic regulation of Keap1-Nrf2 signaling
Guo, Y., Yu, S., Zhang, C., & Kong, A.-N. T. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.013 · Cited by 258
“In addition, the important role of epigenetic modifications in diabetes [19], autoimmune diseases [20], cardiovascular diseases [21], and neurodegenerative diseases [22] has been recognized.”
BackgroundYang, B. T., Dayeh, T. A., Kirkpatrick, C. L., Taneera, J., Kumar, R., Groop, L., Wollheim, C. B., Nitert, M. D., & Ling, C. (2011) · Diabetologia · doi:10.1007/s00125-010-1967-6 · Cited by 251
Self-citationThe Paradox of Progress: Environmental Disruption of Metabolism and the Diabetes Epidemic
Neel, B. A., & Sargis, R. M. (2011) · Diabetes · doi:10.2337/db11-0153 · Cited by 245
“Intriguingly, there is now data demonstrating the epigenetic regulation of various genes influencing metabolic diseases, including diabetes (55).”
BackgroundHall, E., Volkov, P., Dayeh, T., Esguerra, J. L. S., Salö, S., Eliasson, L., Rönn, T., Bacos, K., & Ling, C. (2014) · Genome Biology · doi:10.1186/s13059-014-0522-z · Cited by 249
“Since DNA methylation may regulate gene transcription [30,31], we further examined if any of the genes that exhibit differential DNA methylation due to sex also show different levels of expression in islets from male, compared with female, donors.”
BackgroundSelf-citationEpigenomic disruption: The effects of early developmental exposures
Bernal, A. J., & Jirtle, R. L. (2010) · Birth Defects Research Part A: Clinical and Molecular Teratology · doi:10.1002/bdra.20685 · Cited by 234
“It has been suggested that low exposure levels of EDCs could lead to less overt phenotypes in humans, such as type 2 diabetes, adipogenesis, and behavioral effects (Braun and others, 2009; Ling and Groop, 2009; Sargis and others, 2009; Somm and others, 2009).”
BackgroundMicroRNAs regulating oxidative stress and inflammation in relation to obesity and atherosclerosis
Hulsmans, M., Keyzer, D. D., & Holvoet, P. (2011) · The FASEB Journal · doi:10.1096/fj.11-181149 · Cited by 244
Epigenetic Regulation of Macrophage Polarization by DNA Methyltransferase 3b
Yang, X., Wang, X., Liu, D., Yu, L., Xue, B., & Shi, H. (2014) · Molecular Endocrinology · doi:10.1210/me.2013-1293 · Cited by 237
Galmozzi, A., Mitro, N., Ferrari, A., Gers, E., Gilardi, F., Godio, C., Cermenati, G., Gualerzi, A., Donetti, E., Rotili, D., et al. (2013) · Diabetes · doi:10.2337/db12-0548 · Cited by 235
“Diabetes 62:732–742, 2013 Abnormalities in epigenetic regulation have been associated with multiple metabolic disorders, such as cardiovascular disease, obesity, and type 2 diabetes (1,2).”
BackgroundBacos, K., Gillberg, L., Volkov, P., Olsson, A. H., Hansen, T., Pedersen, O., Gjesing, A. P., Eiberg, H., Tuomi, T., Almgren, P., et al. (2016) · Nature Communications · doi:10.1038/ncomms11089 · Cited by 236
Self-citationEpigenetic phenomena linked to diabetic complications
Pirola, L., Balcerczyk, A., Okabe, J., & El-Osta, A. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.188 · Cited by 239
“Epidemiological and clinical studies now indicate that the development of type 2 diabetes mellitus strongly depends on gene–environment interactions or epigenetic changes that regulate gene expression”
BackgroundEnvironmental epigenetics of asthma: An update
Ho, S.-M. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.07.030 · Cited by 235
Pickering, C., & Kiely, J. (2018) · Sports Medicine · doi:10.1007/s40279-017-0776-1 · Cited by 209
Pirola, L., Balcerczyk, A., Tothill, R. W., Haviv, I., Kaspi, A., Lunke, S., Ziemann, M., Karagiannis, T., Tonna, S., Kowalczyk, A., et al. (2011) · Genome Research · doi:10.1101/gr.116095.110 · Cited by 223
“Defining the epigenetic identity of the vascular cell remains a formidable challenge (Ling and Groop 2009).”
BackgroundEpigenetics: Mechanisms and Implications for Diabetic Complications
Cooper, M. E., & El-Osta, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.223552 · Cited by 213
Cardiovascular Epigenetics: Basic Concepts and Results From Animal and Human Studies
Baccarelli, A., Rienstra, M., & Benjamin, E. J. (2010) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.110.958744 · Cited by 200
Perfilyev, A., Dahlman, I., Gillberg, L., Rosqvist, F., Iggman, D., Volkov, P., Nilsson, E., Risérus, U., & Ling, C. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.143164 · Cited by 198
Self-citationDayeh, T., Tuomi, T., Almgren, P., Perfilyev, A., Jansson, P.-A., de Mello, V. D., Pihlajamäki, J., Vaag, A., Groop, L., Nilsson, E., et al. (2016) · Epigenetics · doi:10.1080/15592294.2016.1178418 · Cited by 194
Self-citationEpigenetic mechanisms in diabetic vascular complications
Reddy, M. A., & Natarajan, R. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr024 · Cited by 199
DNA methylation in the pathogenesis of type 2 diabetes in humans
Davegårdh, C., García-Calzón, S., Bacos, K., & Ling, C. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.01.022 · Cited by 197
“DNMT1 has been suggested to be responsible for copying the methylation pattern during cell replication, while DNMT3A and B have been suggested to be responsible for de novo methylation [1].”
BackgroundInfluentialSelf-citationDayeh, T. A., Olsson, A. H., Volkov, P., Almgren, P., Rönn, T., & Ling, C. (2013) · Diabetologia · doi:10.1007/s00125-012-2815-7 · Cited by 199
“Type 2 diabetes is a heterogeneous disease caused by a complex interplay between multiple genetic, epigenetic and environmental factors [1].”
Self-citationThe role of diet and exercise in the transgenerational epigenetic landscape of T2DM
Barrès, R., & Zierath, J. R. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.87 · Cited by 198
Physical activity in the prevention of human diseases: role of epigenetic modifications
Grazioli, E., Dimauro, I., Mercatelli, N., Wang, G., Pitsiladis, Y., Di Luigi, L., & Caporossi, D. (2017) · BMC Genomics · doi:10.1186/s12864-017-4193-5 · Cited by 193
“Indeed, DNA methylation of the PPARG coactivator 1 alpha (PPARGC1A), a gene that coordinates the expression of several proteins involved in mitochondrial oxidative metabolism in multiple tissues, is elevated in both pancreatic islets [81] and skeletal muscle [82] of patients with T2D, and negatively correlates with gl…”
Epigenetic Regulation at the Interplay Between Gut Microbiota and Host Metabolism
Miro-Blanch, J., & Yanes, O. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00638 · Cited by 195
Olsson, A. H., Volkov, P., Bacos, K., Dayeh, T., Hall, E., Nilsson, E. A., Ladenvall, C., Rönn, T., & Ling, C. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004735 · Cited by 174
Self-citationRajendran, R., Garva, R., Krstic-Demonacos, M., & Demonacos, C. (2011) · BioMed Research International · doi:10.1155/2011/368276 · Cited by 174
Microvesicles/exosomes as potential novel biomarkers of metabolic diseases
Müller, G. (2012) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s32923 · Cited by 170
Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics
Xu, S., Kamato, D., Little, P. J., Nakagawa, S., Pelisek, J., & Jin, Z. G. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.003 · Cited by 173
Obesity and diabetes: from genetics to epigenetics
Burgio, E., Lopomo, A., & Migliore, L. (2015) · Molecular Biology Reports · doi:10.1007/s11033-014-3751-z · Cited by 168
DNA methylation and its role in the pathogenesis of diabetes
Bansal, A., & Pinney, S. E. (2017) · Pediatric Diabetes · doi:10.1111/pedi.12521 · Cited by 171
“Population-based studies demonstrate that the offspring of diabetic mothers have an increased risk for obesity, glucose intolerance, and T2DM.73,74 It has been proposed that early exposure to hyperglycemia and elevated insulin levels may lead to a malprogramming of critical functions related to the development of diab…”
BackgroundInfluentialDNA Modifications: Function and Applications in Normal and Disease States
Liyanage, V. R. B., Jarmasz, J. S., Murugeshan, N., Bigio, M. R. D., Rastegar, M., & Davie, J. (2014) · Biology · doi:10.3390/biology3040670 · Cited by 191
“Among the diverse factors contributing to the pathogenesis of diabetes, epigenetic modifications have attracted attention because they can connect the pathology to environmental cues [141].”
BackgroundDevelopmental Programming of Fetal Skeletal Muscle and Adipose Tissue Development
Yan, X., Zhu, M. J., Dodson, M. V., & Du, . (2013) · Journal of Genomics · doi:10.7150/jgen.3930 · Cited by 179
“Ep-igenetic changes can pass from one cell generation to the next (mitotic inheritance), as well as from one generation of a species to the next (meiotic inheritance) [122].”
Genetic and Epigenetic Regulation in Nonalcoholic Fatty Liver Disease (NAFLD)
Campo, J. A. D., Gallego‐Durán, R., Gallego, P., & Grande, L. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030911 · Cited by 162
“It has been described that aberrant histone modifications promote the development of insulin resistance and, consequently, NAFLD [44].”
BackgroundYuan, H., Reddy, M. A., Sun, G., Lanting, L. L., Wang, M., Kato, M. V., & Natarajan, R. D. (2012) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00523.2012 · Cited by 150
“06-599), p300 (05-257), Sp1 (07-645), normal mouse IgG (12-371), and normal rabbit IgG (PP64B) were from Millipore (Billerica, MA); Smad2/3 (8685), acetylated-lysine (9441), HDAC1 (2062), and HDAC5 (2082) antibodies were from Cell Signaling (Danvers, MA); the CBP antibody (ab3652) was from Abcam (Cambridge, MA); the -…”
BackgroundMethodInfluentialHall, E., Volkov, P., Dayeh, T., Bacos, K., Rönn, T., Nitert, M. D., & Ling, C. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-103 · Cited by 148
“Recent studies suggest that epigenetic factors, such as DNA methylation, play a role in the pathogenesis of T2D [3-11].”
Self-citationAgardh, E., Lundstig, A., Perfilyev, A., Volkov, P., Freiburghaus, T., Lindholm, E., Rönn, T., Agardh, C., & Ling, C. (2015) · BMC Medicine · doi:10.1186/s12916-015-0421-5 · Cited by 143
“Epigenetic modifications, such as DNA methylation and histone modifications, influence many cellular processes including regulation of gene transcription, embryonic development, X chromosome inactivation, and genomic imprinting [5].”
Self-citationEpigenetics in non-alcoholic fatty liver disease
Lee, J.-H., Kim, Y., Friso, S., & Choi, S. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.11.008 · Cited by 152
Food, Nutrigenomics, and Neurodegeneration—Neuroprotection by What You Eat!
Virmani, A., Pinto, L., Binienda, Z., & Ali, S. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8498-3 · Cited by 137
Targeting metabolic disorders by natural products
Tabatabaei‐Malazy, O., Larijani, B. A., & Abdollahi, M. R. (2015) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/s40200-015-0184-8 · Cited by 138
“There are some evidences that epigenetic factors may contribute to diabetes [17–19].”
BackgroundAir Pollution as a Risk Factor for Type 2 Diabetes
Rao, X., Patel, P., Puett, R. C., & Rajagopalan, S. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu250 · Cited by 136
“It is possible that familial clustering of T2DM may have little to do with genetics, but may simply reflect shared environmental risk factors (eg sedentary lifestyle, pollutant exposures and gut flora to name a few) (Adamo and Tesson, 2008; Ling and Groop, 2009).”
BackgroundGranata, C., Jamnick, N. A., & Bishop, D. J. (2018) · Sports Medicine · doi:10.1007/s40279-018-0894-4 · Cited by 148
Losartan reverses permissive epigenetic changes in renal glomeruli of diabetic db/db mice
Reddy, M. A., Putta, S., Lanting, L. L., Yuan, H., Wang, M., Mar, D., Alpers, C. E., Bomsztyk, K., & Natarajan, R. D. (2013) · Kidney International · doi:10.1038/ki.2013.387 · Cited by 137
Epigenetic regulation on gene expression induced by physical exercise.
Ntanasis‐Stathopoulos, I., Tzanninis, J. G., Philippou, Α., & Koutsilieris, M. (2013) · PubMed · Cited by 162
Stress and the epigenetic landscape: a link to the pathobiology of human diseases?
Johnstone, S. E., & Baylin, S. B. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2881 · Cited by 132
“Robust experimental observations are allowing us to think about roles for altered epigenetic states and abnormal cell fates induced by stress in diabete”
BackgroundEpigenetics: deciphering its role in diabetes and its chronic complications
Villeneuve, L. M., Reddy, M. A., & Natarajan, R. D. (2011) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2011.05497.x · Cited by 131
DNA Methylation in Inflammatory Genes among Children with Obstructive Sleep Apnea
Kim, J., Bhattacharjee, R., Khalyfa, A., Gozal, D., Capdevila, Ó. S., Wang, Y., & Gozal, D. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201106-1026oc · Cited by 131
Sailani, M. R., Halling, J. F., Møller, H. D., Lee, H., Plomgaard, P., Pilegaard, H., Snyder, M. P., & Regenberg, B. (2019) · Scientific Reports · doi:10.1038/s41598-018-37895-8 · Cited by 129
Volkov, P., Olsson, A. H., Gillberg, L., Jørgensen, S. W., Brøns, C., Eriksson, K., Groop, L., Jansson, P., Nilsson, E., Rönn, T., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157776 · Cited by 150
Self-citationPerrino, C., Barabási, A.-Ĺ., Condorelli, G., Davidson, S. M., Windt, L. J. D., Dimmeler, S., Engel, F. B., Hausenloy, D. J., Hill, J. A., Laake, L. W. V., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx070 · Cited by 127
The Role of Redox Signaling in Epigenetics and Cardiovascular Disease
Kim, G. H., Ryan, J. J., & Archer, S. L. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4926 · Cited by 130
“DNA methylation states may also vary over an individual’s lifetime, and only recently have these alterations been studied in the realm of CVDs, such as atherosclerosis, inflammation, hypertension, and diabetes (42,80).”
Epigenetic Mechanisms Underlying the Link between Non-Alcoholic Fatty Liver Diseases and Nutrition
Lee, J. Y., Friso, S., & Choi, S. (2014) · Nutrients · doi:10.3390/nu6083303 · Cited by 137
“Aberrant histone modifications contribute to the development of insulin resistance and consequently to fatty liver disease [85].”
BackgroundTwin methodology in epigenetic studies
Tan, Q., Christiansen, L., Hjelmborg, J., & Christensen, K. (2015) · Journal of Experimental Biology · doi:10.1242/jeb.107151 · Cited by 125
Gilbert, E. R., & Liu, D. (2012) · Epigenetics · doi:10.4161/epi.21238 · Cited by 139
Dynamic DNA methylation of matrix metalloproteinase-9 in the development of diabetic retinopathy
Kowluru, R. A., Shan, Y., & Mishra, M. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2016.78 · Cited by 127
DNA methylation of the glucagon-like peptide 1 receptor (GLP1R) in human pancreatic islets
Hall, E., Dayeh, T., Kirkpatrick, C. L., Wollheim, C. B., Nitert, M. D., & Ling, C. (2013) · BMC Medical Genetics · doi:10.1186/1471-2350-14-76 · Cited by 121
“Indeed, our group has previously demonstrated that DNA methylation correlates negatively with type 2 diabetes candidate gene expression in human pancreatic islets and skeletal muscle [7-12].”
Self-citationEpigenetic adaptation to regular exercise in humans
Ling, C., & Rönn, T. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.03.006 · Cited by 143
Self-citationLi, F., Wu, R., Cui, X., Zha, L., Yu, L., Shi, H., & Xue, B. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677930 · Cited by 120
SIRT1, p66Shc, and Set7/9 in Vascular Hyperglycemic Memory
Paneni, F., Volpe, M., Lüscher, T. F., & Cosentino, F. (2013) · Diabetes · doi:10.2337/db12-1648 · Cited by 118
A Review of Emerging Technologies for the Management of Diabetes Mellitus
Zarkogianni, K., Litsa, E. E., Mitsis, K., Wu, P.-Y., Kaddi, C. D., Cheng, C., Wang, M. D., & Nikita, K. S. (2015) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2015.2470521 · Cited by 142
“to T2DM [119], [120].”
Epigenetic Regulation of TNFA Expression in Periodontal Disease
Zhang, S., Barros, S. P., Moretti, A. J., Yu, N., Zhou, J., Preisser, J. S., Niculescu, M. D., & Offenbacher, S. (2013) · Journal of Periodontology · doi:10.1902/jop.2013.120294 · Cited by 116
Recent developments in epigenetics of acute and chronic kidney diseases
Reddy, M. A., & Natarajan, R. D. (2015) · Kidney International · doi:10.1038/ki.2015.148 · Cited by 115
In UteroProgramming of Later Adiposity: The Role of Fetal Growth Restriction
Sarr, O., Yang, K., & Regnault, T. R. H. (2012) · Journal of Pregnancy · doi:10.1155/2012/134758 · Cited by 115
“Low levels of DNA methylation, particularly at gene promoter regions, have been proposed to generate active genes [114].”
BackgroundEpigenetic regulation of insulin action and secretion – role in the pathogenesis of type 2 diabetes
Ling, C. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13049 · Cited by 115
Self-citationDNA Methylation as a Diagnostic and Therapeutic Target in the Battle Against Type 2 Diabetes
Rönn, T., & Ling, C. (2015) · Epigenomics · doi:10.2217/epi.15.7 · Cited by 111
Self-citationEpigenetic Modifications and Diabetic Retinopathy
Kowluru, R. A., dos Santos, J. M., & Mishra, M. (2013) · BioMed Research International · doi:10.1155/2013/635284 · Cited by 115
The Play of Genes and Non-genetic Factors on Type 2 Diabetes
Mambiya, M., Shang, M., Wang, Y., Li, Q., Liu, S., Yang, L., Zhang, Q., Zhang, K., Liu, M., Nie, F., et al. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2019.00349 · Cited by 121
“Epigenetics which include DNA methylations, histone modifications, and microRNAs is the heritability alteration or change in gene functions, that do not involve changes in nucleotide sequence and is said to explain a portion of the pathogenesis of chronic diseases as it suggests that these modifications can be passed…”
BackgroundImplications of time-series gene expression profiles of replicative senescence.
Kim, Y., Byun, H., Jee, B. A., Cho, H., Seo, Y., Kim, Y., Park, M. H., Chung, H., Woo, H. G., & Yoon, G. (2013) · Aging Cell · doi:10.1111/acel.12087 · Cited by 106
Economic development and diabetes prevalence in MENA countries: Egypt and Saudi Arabia comparison
Sherif, S., & Sumpio, B. E. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i2.304 · Cited by 111
Abderrahmani, A., Yengo, L., Caiazzo, R. J., Canouil, M., Cauchi, S., Raverdy, V., Plaisance, V., Pawlowski, V., Lobbens, S., Maillet, J., et al. (2018) · Diabetes · doi:10.2337/db17-1539 · Cited by 118
Malan‐Müller, S., Kilian, S., van den Heuvel, L. L., Bardien, S., Asmal, L., Warnich, L., Emsley, R. A., Hemmings, S. M. J., & Seedat, S. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.11.011 · Cited by 112
Epigenetic modulation of macrophage polarization- perspectives in diabetic wounds
Mallik, S. B., Jayashree, B. S., & Shenoy, R. R. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.01.015 · Cited by 108
Metadata
- Authors
- Ling, C., & Groop, L.
- Affiliations
- Lund University (SE)
- Corresponding author
- Ling, Charlotte
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-12-01
- Volume
- 58
- Issue
- 12
- Pages
- 2718-2725
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2780862
- OpenAlex
- W2164575981
- Cited by
- 617
- References
- 117
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 20 · 2023: 35 · 2022: 24 · 2021: 35 · 2020: 39 · 2019: 50 · 2018: 49 · 2017: 56 · 2016: 44 · 2015: 58 · 2014: 41 · 2013: 49 · 2012: 36
- FWCI
- 2.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Eli Lilly and Company
- Lunds Universitet
- Vetenskapsrådet
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- epigenetics, type 2 diabetes, environmental risk factors, gene-environment interaction, obesity, physical inactivity, aging, genetic susceptibility, epigenetic regulation
- MeSH terms
- Aging, Animals, Diabetes Mellitus, Type 2, Energy Metabolism, Food, Histones, Humans, Infant, Newborn, Obesity, Risk Factors, Transcription, Genetic, Exercise, DNA Methylation, MicroRNAs, Epigenesis, Genetic, Diabetes Complications
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.